Clin2
NCT03104569Possibly a fitNot yet recruiting

37°C contrast fluid during ERCP for bile duct cancer

Cholangitis

Part of Cancer, Digestive system clinical trials.

This trial studies whether using contrast dye at 37°C (body temperature) during an ERCP procedure helps people with hilar cholangiocarcinoma. If you are having ERCP for this cancer, the study compares the contrast approach to see if it is safer or works better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are diagnosed with hilar cholangiocarcinoma type 1, 2, 3, or 4
  • You are between 18 and 90 years old
  • You are scheduled to have ERCP (a scope procedure to the bile ducts) for diagnosis or treatment
  • Your blood clotting tests are not significantly abnormal (INR must be 1.3 or less) and platelets are not too low
  • You do not have active serious problems before the procedure (like acute cholangitis or acute pancreatitis)
  • You are not pregnant, and the ERCP is your first one (no previous ERCP), with no certain prior bile-duct/intestinal surgeries

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06613945Recruiting
Comparing two ways to open blocked bile ducts in liver cancer

This study compares two procedures to drain bile from the liver in people with blocked bile ducts caused by cancer that cannot be removed. It looks at whether using an ultrasound-guided approach along with standard ERCP works better than ERCP alone.

Al Mansurah, Dakahlia Governorate
NCT07120295Recruiting· Phase 4
Study of a new scope for bile duct problems

This trial tests a special scope that helps doctors see inside the bile duct during an ERCP procedure. It may help people with blocked bile ducts that can't be treated with standard methods.

Aurora, Colorado
NCT07235007Recruiting
New treatment for bile duct cancer with heat, immunotherapy, and chemo

This trial tests a combination of heat therapy inside the bile duct (endobiliary RFA) with immunotherapy (durvalumab) and chemotherapy (gemcitabine and cisplatin) for people with unresectable extrahepatic cholangiocarcinoma. The goal is to see if adding the heat treatment improves outcomes.

Aichi
NCT03921502Recruiting
ERCP vs ERCP with a stomach drainage procedure comparison

This trial compares two endoscopy approaches to drain a blocked bile duct caused by gallstones. It may help people who can’t safely have standard surgery decide which drainage method works best after an initial ERCP plan fails or is limited.

Valladolid
NCT07389915Not yet recruiting
AI for difficult gallbladder tube placement

This trial tests if a computer program can help doctors place a tube into the bile duct more easily during a procedure called ERCP. It may help people who need this procedure for bile duct problems.

NCT07329803Not yet recruiting
Two ways to reach the bile duct during ERCP: a comparison study

This study compares two techniques used when doctors have trouble placing a wire into the bile duct during an ERCP procedure. It looks at which method might be safer and more successful for patients with bile duct blockages.

Hear when a new Cholangitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.